Company page

Immuneonco Biopharmaceuticals (shanghai) Inc Class H

Immuneonco Biopharmaceuticals (Shanghai) Inc Class H, trading under the ticker 1541 on the Hong Kong market, has a market capitalization of approximately HKD 387.25 million. The company focuses on biopharmaceutical development, aiming to advance innovative therapies. Investors can find relevant information and updates about the company on its public page.